Free worldwide shipping on every order

Medical Disclaimer

This information is for educational purposes only and is not intended as medical advice. Red light therapy is not a substitute for professional medical treatment. Always consult your healthcare provider before starting any new therapy, especially for diagnosed medical conditions.

Red Light Therapy for Hair Loss

Red light therapy for hair loss

Liu 2019 (Lasers in Medical Science) meta-analysis of 8 trials / 11 comparisons found LLLT significantly increased hair density vs sham (SMD 1.32) in both sexes, with both comb- and helmet-type devices effective. FDA has cleared multiple at-home red-light devices for AGA since 2007, and ISHRS recognizes LLLT as a non-pharmacological option suitable as adjunct or alternative to minoxidil/finasteride.

Evidence
Strong
Dose
3-4 J/cm² per session typical home-device dose; 650 nm at ~5 mW per diode, 8-25 minute sessions per FDA-cleared device parameters J/cm²
Wavelengths
630, 650, 655, 660, 670, 678 nm
Session
8-25 minutes per session (device-dependent) min
Frequency
3-7 (low-frequency subgroup superior per Liu 2019)×/wk

TL;DR

Yes, red light therapy for hair loss may help some people. It is best used as a consistent photobiomodulation routine alongside diagnosis-led care, rehab, sleep, and lifestyle basics.

Evidence-backed quick protocol

Photobiomodulation research supports plausible effects on cellular energy, nitric oxide signaling, pain mediators, and inflammatory balance for this use case [Jimenez 2014, PMID:24474647; Fan 2018, PMID:29957664]. Match wavelength depth, treatment area, and irradiance before judging results.

  1. Target the full tissue field: Treat the symptomatic area plus nearby muscles, tendons, joints, or nerve pathway.
  2. Start repeatably: Use 10-20 minutes per area, 3-5 times weekly for 4-8 weeks unless your clinician advises otherwise.
  3. Track function: Measure pain, stiffness, sleep, range of motion, and return-to-activity instead of one-session changes.
  4. Choose enough coverage: Consider RLPRO 1000 for practical home coverage, and compare context in home vs clinic red light therapy.

For adjacent symptoms, compare this guide with skin rejuvenation.

Understanding Hair Loss

Hair loss (alopecia) affects millions of men and women worldwide. Androgenetic alopecia — commonly known as male- or female-pattern hair loss — is the most prevalent form, driven by genetic predisposition and hormonal factors involving dihydrotestosterone (DHT). Other forms include alopecia areata (autoimmune), telogen effluvium (stress-related shedding), and traction alopecia (from chronic pulling).

The hair growth cycle consists of three phases: anagen (growth, 2–7 years), catagen (transition, 2–3 weeks), and telogen (rest/shedding, 3 months). In androgenetic alopecia, DHT progressively miniaturises follicles, shortening the anagen phase and producing thinner, shorter hairs until the follicle ceases producing visible hair.

Current medical treatments include minoxidil (topical), finasteride (oral, for men), and hair transplant surgery. Red light therapy has emerged as an FDA-cleared complementary treatment for hair loss.

How Red Light Therapy May Help

Low-level light therapy (LLLT) for hair loss — a form of photobiomodulation — proposes several mechanisms:

  • Follicle cell stimulation: Red light (630–670 nm) is absorbed by chromophores in hair follicle cells, potentially stimulating dermal papilla cells and keratinocytes to re-enter or prolong the anagen growth phase.
  • Increased ATP production: Enhanced mitochondrial function in follicular cells may provide the energy needed for active hair growth.
  • Scalp blood flow: Nitric oxide release induced by PBM may improve microcirculation in the scalp, delivering more oxygen and nutrients to hair follicles.
  • Anti-inflammatory effects: Chronic scalp inflammation (often sub-clinical) may contribute to follicular miniaturisation; PBM may help modulate this inflammatory response.
  • Reduced oxidative stress: Oxidative stress has been implicated in premature follicular ageing; PBM may help restore redox balance in the scalp.

What the Research Says

LLLT for hair loss has one of the strongest evidence bases in the photobiomodulation field. A 2014 meta-analysis published in Lasers in Surgery and Medicine evaluated 11 RCTs and concluded that LLLT significantly increased hair density in patients with androgenetic alopecia compared with sham devices.

A 2017 randomised, double-blind trial in the American Journal of Clinical Dermatology reported a 37% increase in hair count after 26 weeks of LLLT. The FDA has cleared several LLLT devices for the treatment of hair loss in both men and women, classifying them under medical device regulations.

A comprehensive 2019 review in Skin Appendage Disorders summarised that LLLT at wavelengths between 630 and 670 nm appears most effective for hair growth, with some evidence supporting near-infrared wavelengths for deeper follicular penetration.

Optimal Wavelengths

The strongest clinical evidence for hair growth is at 650–670 nm (red), though some studies also report benefits from 810–850 nm (NIR) for reaching the base of deeper follicles in the scalp.

Recommended Usage Protocol

  • Distance: 15–25 cm from the scalp.
  • Session duration: 15–20 minutes per session.
  • Frequency: Every other day (3–4 sessions per week) for a minimum of 16–26 weeks.
  • Consistency: Hair growth results require patience — most studies report noticeable improvements at 12–26 weeks.
  • Documentation: Photograph the scalp under consistent lighting every 4 weeks to track progress.

Which Hale Panel Is Best for Hair Loss?

The RLPRO 1000 (720 LEDs, 153 × 42 cm) provides excellent scalp coverage for standing or seated treatment sessions. Its eight-wavelength output includes the 630, 650, 660, and 670 nm red wavelengths most strongly associated with hair growth, along with near-infrared wavelengths for deeper penetration.

For users who wish to combine hair loss treatment with full-body skin or recovery sessions, the RLPRO 1200 offers additional versatility.

Complementary Hair Loss Strategies

  • Consult a dermatologist for a proper diagnosis and personalised treatment plan
  • Consider medical therapies (minoxidil, finasteride) as recommended by your doctor
  • Ensure adequate protein, iron, zinc, and biotin intake
  • Manage stress — a known trigger for telogen effluvium
  • Avoid harsh chemical treatments and excessive heat styling
  • Gentle scalp massage to promote blood flow

Red light therapy may offer a non-invasive, side-effect-free approach to supporting hair growth that can be used alongside medical treatments for androgenetic alopecia and other forms of hair thinning.

Frequently Asked Questions

Does red light therapy for hair loss work?

red light therapy for hair loss may help some people, especially when the target tissue, wavelength depth, and session schedule are consistent. It is not a guaranteed cure and should not replace medical evaluation.

How often should I use red light therapy for hair loss?

A practical starting point is 3-5 sessions per week for 4-8 weeks. Use the same distance and time so changes in pain, stiffness, sleep, or function are easier to interpret.

Which wavelengths matter for hair loss?

Red wavelengths are useful for superficial tissue, while near-infrared wavelengths are more relevant for deeper joints, muscles, tendons, and nerve pathways. Coverage and dose matter as much as wavelength names.

Can red light therapy for hair loss replace treatment?

No. Use PBM as a complementary tool. Keep prescribed medications, rehab plans, wound care, and specialist follow-up in place unless your healthcare provider changes them.

Calculate your protocol

Get a hair loss protocol calibrated to your Hale panel

Free tool. Pick your condition, get the recommended wavelength split, session time, and J/cm² target — all based on measured Hale panel irradiance.

Recommended Hale Panels

Panels best suited for hair loss treatment. Health Canada Class II & FDA-listed, with 8 wavelengths (630–1060 nm).

Evidence reference

Hair Loss is one of 27 conditions in Hale's PBM Dose Canonical Table — a peer-reviewed-evidence-sourced reference document with the consensus dose range, wavelengths, and protocol parameters cited to verifiable PMIDs.

See the row for hair loss